{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:47:28Z","timestamp":1792025248714,"version":"4.4.0"},"publisher-location":"Cham","reference-count":19,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032353863","type":"print"},{"value":"9783032353870","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-3-032-35387-0_19","type":"book-chapter","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:03:42Z","timestamp":1786439022000},"page":"259-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of\u00a0Temporal Harmonization on\u00a0Patient Trajectory Analysis in\u00a0Multiple Sclerosis"],"prefix":"10.1007","author":[{"given":"Niels","family":"Jodts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorin","family":"Werthen-Brabants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Herzeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Meertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Wuyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Van Wijmeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbet","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Dhaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Deschrijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"7","key":"19_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000533","volume":"3","author":"E De Brouwer","year":"2024","unstructured":"De Brouwer, E., et al.: Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study. PLOS Digit. Health 3(7), e0000533 (2024). https:\/\/doi.org\/10.1371\/journal.pdig.0000533","journal-title":"PLOS Digit. Health"},{"issue":"5","key":"19_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa0902533","volume":"362","author":"G Giovannoni","year":"2010","unstructured":"Giovannoni, G., et al.: CLARITY Study Group: a placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N. Engl. J. Med. 362(5), 416\u2013426 (2010). https:\/\/doi.org\/10.1056\/NEJMoa0902533","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"19_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41512-020-00077-0","volume":"4","author":"RHH Groenwold","year":"2020","unstructured":"Groenwold, R.H.H.: Informative missingness in electronic health record systems: the curse of knowing. Diagn. Prognostic Res. 4(1), 8 (2020). https:\/\/doi.org\/10.1186\/s41512-020-00077-0","journal-title":"Diagn. Prognostic Res."},{"issue":"11","key":"19_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000384","volume":"2","author":"C Herzeel","year":"2023","unstructured":"Herzeel, C., et al.: A software package for efficient patient trajectory analysis applied to analyzing bladder cancer development. PLOS Digit. Health 2(11), e0000384 (2023). https:\/\/doi.org\/10.1371\/journal.pdig.0000384","journal-title":"PLOS Digit. Health"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"1758416","DOI":"10.3389\/fimmu.2026.1758416","volume":"17","author":"N Jodts","year":"2026","unstructured":"Jodts, N., et al.: Data-driven hypothesis discovery from disease trajectories in multiple sclerosis. Front. Immunol. 17, 1758416 (2026). https:\/\/doi.org\/10.3389\/fimmu.2026.1758416","journal-title":"Front. Immunol."},{"issue":"14","key":"19_CR6","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1177\/1352458519848965","volume":"25","author":"T Kalincik","year":"2019","unstructured":"Kalincik, T., Butzkueven, H.: The MSBase registry: informing clinical practice. Mult. Scler. 25(14), 1828\u20131834 (2019). https:\/\/doi.org\/10.1177\/1352458519848965","journal-title":"Mult. Scler."},{"issue":"7","key":"19_CR7","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","volume":"67","author":"L Kappos","year":"2006","unstructured":"Kappos, L., et al.: Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67(7), 1242\u20131249 (2006). https:\/\/doi.org\/10.1212\/01.wnl.0000237641.33768.8d","journal-title":"Neurology"},{"issue":"3","key":"19_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.msard.2015.04.001","volume":"4","author":"L Kappos","year":"2015","unstructured":"Kappos, L., D\u2019Souza, M., Lechner-Scott, J., Lienert, C.: On the origin of Neurostatus. Multiple Sclerosis Relat. Disord. 4(3), 182\u2013185 (2015). https:\/\/doi.org\/10.1016\/j.msard.2015.04.001","journal-title":"Multiple Sclerosis Relat. Disord."},{"issue":"1","key":"19_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan, G., Hashim, M.J.: Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J. Epidemiol. Glob. Health 15(1), 21 (2025). https:\/\/doi.org\/10.1007\/s44197-025-00353-6","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"5","key":"19_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen, N., S\u00f8rensen, P.S.: The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9(5), 520\u2013532 (2010). https:\/\/doi.org\/10.1016\/S1474-4422(10)70064-8","journal-title":"Lancet Neurol."},{"key":"19_CR11","doi-asserted-by":"publisher","unstructured":"Lublin, F.D., et al.: How patients with multiple sclerosis acquire disability. Brain J. Neurol. 145(9), 3147\u20133161 (2022). https:\/\/doi.org\/10.1093\/brain\/awac016","DOI":"10.1093\/brain\/awac016"},{"issue":"1","key":"19_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald, W.I., et al.: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50(1), 121\u2013127 (2001). https:\/\/doi.org\/10.1002\/ana.1032","journal-title":"Ann. Neurol."},{"issue":"2","key":"19_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458517751049","volume":"24","author":"X Montalban","year":"2018","unstructured":"Montalban, X., et al.: ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult. Scler. 24(2), 96\u2013120 (2018). https:\/\/doi.org\/10.1177\/1352458517751049","journal-title":"Mult. Scler."},{"issue":"2","key":"19_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C.H., et al.: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69(2), 292\u2013302 (2011). https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann. Neurol."},{"issue":"6","key":"19_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C.H., et al.: Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u2019\u2019. Ann. Neurol. 58(6), 840\u2013846 (2005). https:\/\/doi.org\/10.1002\/ana.20703","journal-title":"Ann. Neurol."},{"issue":"2","key":"19_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A.J., et al.: Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17(2), 162\u2013173 (2018). https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol."},{"key":"19_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.sigpro.2019.107299","volume":"167","author":"C Truong","year":"2020","unstructured":"Truong, C., Oudre, L., Vayatis, N.: Selective review of offline change point detection methods. Signal Process. 167, 107299 (2020). https:\/\/doi.org\/10.1016\/j.sigpro.2019.107299","journal-title":"Signal Process."},{"issue":"1","key":"19_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1137\/040608635","volume":"30","author":"S Van Dongen","year":"2008","unstructured":"Van Dongen, S.: Graph clustering via a discrete uncoupling process. SIAM J. Matrix Anal. Appl. 30(1), 121\u2013141 (2008). https:\/\/doi.org\/10.1137\/040608635","journal-title":"SIAM J. Matrix Anal. Appl."},{"issue":"11","key":"19_CR19","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.3390\/ijms23115877","volume":"23","author":"J Yang","year":"2022","unstructured":"Yang, J., et al.: Current and future biomarkers in multiple sclerosis. Int. J. Mol. Sci. 23(11), 5877 (2022). https:\/\/doi.org\/10.3390\/ijms23115877","journal-title":"Int. J. Mol. Sci."}],"container-title":["Lecture Notes in Computer Science","Artificial Intelligence in Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-35387-0_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:16:10Z","timestamp":1792023370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-35387-0_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"ISBN":["9783032353863","9783032353870"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-35387-0_19","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"value":"0302-9743","type":"print"},{"value":"1611-3349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"12 August 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The studies involving humans were approved by the Faculty of Medicine and Life Sciences Commission for Medical Ethics Hasselt University (CME2019\/046). The studies were conducted in accordance with local legislation and institutional requirements. The ethics committee\/institutional review board waived the requirement of written informed consent for participation from the participants or the participants\u2019 legal guardians\/next of kin because the retrospective design and the use of anonymized data align with both national law and international ethical guidelines for retrospective research.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Disclosure of Interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"AIiH","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on AI in Healthcare","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"London","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"United Kingdom","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2026","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"26 August 2026","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"28 August 2026","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"3","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"aiih2026","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/aiih.cc\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}